CVS PHARMACY: Completes Rollout of Time Delay Safes in All of Its Tennessee Pharmacies
New safes for controlled substances will help combat opioid epidemic in the state and reduce robbery incidents Read More »
SALIC PHARMACEUTICALS: Launches National Initiatives Aimed At Improving Recognition Of IBS Symptoms, Early Diagnosis And Treatment
In Honor of April's IBS Awareness Month, Efforts Highlight Advances in Research Read More »
ALKERMES: Announces Positive Topline Results From Innovative Study of ARISTADA® and INVEGA SUSTENNA® for the Treatment of Schizophrenia
Large, randomized ALPINE trial showed both long-acting injectable medications effectively controlled schizophrenia symptoms throughout six-month study Read More »
EMD SERONO: MAVENCLAD® (Cladribine) Tablets Now Covered by Express Scripts
Within a week of FDA approval, MAVENCLAD has formulary coverage with one of the leading pharmacy benefit managers in the U.S. Read More »
ONEPOINT PATIENT CARE: To Open Five New Hospice Dedicated Pharmacies
Nationwide demand for local pharmacy model fuels expansion Read More »
AMERICAN SOCIETY OF CANNABIS MEDICINE: Board of Regents Member Dr. Annabelle Manalo Addresses Pharmacy Leaders
Dr. Annabelle Manalo on Wednesday and Today met over 400 members of the Pharmacy Society of Wisconsin including each of its board members of the Pharmacy Society of Wisconsin. Read More »
NOVARTIS PHARMACEUTICALS: Rapha Capital Management Participates in Series C Financing for Poseida Therapeutics, Inc. Led by Novartis Pharmaceuticals
Rapha Capital Management, LLC (https://www.raphacap.com), an investment management firm located in Miami, Florida, and their associated entities announced their participation in a Series C financing for Poseida Therapeutics ("Poseida"). Read More »
AMERISOURCE BERGEN: US Bioservices Selected by Biocodex SAS to Exclusively Dispense DIACOMIT® (stiripentol)
AmerisourceBergen issued the following announcement on April 24.Original source can be found here. Read More »
Alerts Sign-up